These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20676947)

  • 61. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
    Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
    Tseng YC; Wu CY; Liu ML; Chen TH; Chiang WL; Yu YH; Jan JT; Lin KI; Wong CH; Ma C
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4200-4205. PubMed ID: 30782805
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preclinical study of influenza bivalent vaccine delivered with a two compartmental microneedle array.
    Jeong HR; Bae JY; Park JH; Baek SK; Kim G; Park MS; Park JH
    J Control Release; 2020 Aug; 324():280-288. PubMed ID: 32439360
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microneedle patches: usability and acceptability for self-vaccination against influenza.
    Norman JJ; Arya JM; McClain MA; Frew PM; Meltzer MI; Prausnitz MR
    Vaccine; 2014 Apr; 32(16):1856-62. PubMed ID: 24530146
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
    Chung KY; Coyle EM; Jani D; King LR; Bhardwaj R; Fries L; Smith G; Glenn G; Golding H; Khurana S
    Vaccine; 2015 Jul; 33(32):3953-62. PubMed ID: 26093202
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities.
    Hodgins B; Pillet S; Landry N; Ward BJ
    PLoS One; 2019; 14(1):e0210009. PubMed ID: 30629622
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influenza Vaccines toward Universality through Nanoplatforms and Given by Microneedle Patches.
    Tang S; Zhu W; Wang BZ
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33114336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
    Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
    Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a thermostable microneedle patch for influenza vaccination.
    Mistilis MJ; Bommarius AS; Prausnitz MR
    J Pharm Sci; 2015 Feb; 104(2):740-9. PubMed ID: 25448542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.
    Kim KH; Lee YT; Park S; Jung YJ; Lee Y; Ko EJ; Kim YJ; Li X; Kang SM
    Virology; 2019 Sep; 535():179-188. PubMed ID: 31310875
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intradermal Administration of Influenza Vaccine with Trehalose and Pullulan-Based Dissolving Microneedle Arrays.
    Tian Y; Lee J; van der Maaden K; Bhide Y; de Vries-Idema JJ; Akkerman R; O'Mahony C; Jiskoot W; Frijlink HW; Huckriede ALW; Hinrichs WLJ; Bouwstra JA; Beukema M
    J Pharm Sci; 2022 Apr; 111(4):1070-1080. PubMed ID: 35122832
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.
    Lau YF; Tang LH; McCall AW; Ooi EE; Subbarao K
    J Virol; 2010 Sep; 84(17):8639-49. PubMed ID: 20538850
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
    Zheng D; Chen S; Qu D; Chen J; Wang F; Zhang R; Chen Z
    Vaccine; 2016 Dec; 34(51):6464-6471. PubMed ID: 27866773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge.
    Gao X; Wang W; Li Y; Zhang S; Duan Y; Xing L; Zhao Z; Zhang P; Li Z; Li R; Wang X; Yang P
    Antiviral Res; 2013 Apr; 98(1):4-11. PubMed ID: 23416215
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progress in the development of virus-like particle vaccines against respiratory viruses.
    Quan FS; Basak S; Chu KB; Kim SS; Kang SM
    Expert Rev Vaccines; 2020 Jan; 19(1):11-24. PubMed ID: 31903811
    [No Abstract]   [Full Text] [Related]  

  • 77. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets.
    Ross TM; Mahmood K; Crevar CJ; Schneider-Ohrum K; Heaton PM; Bright RA
    PLoS One; 2009 Jun; 4(6):e6032. PubMed ID: 19554101
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses.
    Schepens B; Vos PJ; Saelens X; van der Maaden K
    Eur J Pharm Biopharm; 2019 Mar; 136():259-266. PubMed ID: 30731115
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses.
    Liu J; Ren Z; Wang H; Zhao Y; Wilker PR; Yu Z; Sun W; Wang T; Feng N; Li Y; Wang H; Ji X; Li N; Yang S; He H; Qin C; Gao Y; Xia X
    Int Immunopharmacol; 2018 Oct; 63():119-128. PubMed ID: 30081250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.